Deconvoluting interrelationships between concentrations and chemical shifts in urine provides a powerful analysis tool

The NMR chemical shifts of a substance in a complex mixture strongly depend on the composition of the mixture itself, as many weak interactions occur that are hardly predictable. Chemical shift variability is the major obstacle to automatically assigning, and subsequently quantitating, metabolite signals in body fluids, particularly urine. Here we demonstrate that the chemical shifts of signals in urine are actually predictable. This is achieved by constructing ca. 4000 artificial mixtures where the concentrations of 52 most abundant urine metabolites—including 11 inorganic ions—are varied, to sparsely but efficiently populate an N-dimensional concentration matrix. A strong relationship is established between the concentration matrix and the chemical shift matrix, so that chemical shifts of > 90 metabolite signals can be accurately predicted in real urine samples. The concentrations of the invisible inorganic ions are also accurately predicted, along with those of albumin and of several other abundant urine components.The NMR chemical shifts of a substance in urine strongly depend on the composition of the mixture itself, and this makes automatic assignment for quantification very difficult. Here the authors show the chemical shifts of signals and the concentration of NMR-invisible inorganic ions in urine, are predictable.

[1]  J. Peti-Peterdi High glucose and renin release: the role of succinate and GPR91. , 2010, Kidney international.

[2]  J. Morley,et al.  Abnormal zinc metabolism in type II diabetes mellitus. , 1983, The American journal of medicine.

[3]  L. Tenori,et al.  Allostasis and Resilience of the Human Individual Metabolic Phenotype. , 2015, Journal of proteome research.

[4]  A. El-Aneed,et al.  Mass spectrometric based approaches in urine metabolomics and biomarker discovery. , 2017, Mass spectrometry reviews.

[5]  Maria De Iorio,et al.  Bayesian deconvolution and quantification of metabolites in complex 1D NMR spectra using BATMAN , 2014, Nature Protocols.

[6]  A. Arcasoy,et al.  Hyperzincuria and selective aminoaciduria in thalassemia , 2000 .

[7]  David S. Wishart,et al.  Recommendations and Standardization of Biomarker Quantification Using NMR-Based Metabolomics with Particular Focus on Urinary Analysis , 2016, Journal of proteome research.

[8]  J. Friedman Estimating Functions of Mixed Ordinal and Categorical Variables Using Adaptive Splines , 1991 .

[9]  David S. Wishart,et al.  Accurate, Fully-Automated NMR Spectral Profiling for Metabolomics , 2014, PloS one.

[10]  D. Wishart,et al.  Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review , 2014, Metabolomics.

[11]  Ivano Bertini,et al.  Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks , 2011, Journal of biomolecular NMR.

[12]  R. McKay How the 1D‐NOESY suppresses solvent signal in metabonomics NMR spectroscopy: An examination of the pulse sequence components and evolution , 2011 .

[13]  E. Want,et al.  Global metabolic profiling procedures for urine using UPLC–MS , 2010, Nature Protocols.

[14]  Edoardo Saccenti,et al.  Individual human phenotypes in metabolic space and time. , 2009, Journal of proteome research.

[15]  William S. Ball,et al.  X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. , 2001, American journal of human genetics.

[16]  Cheng Zheng,et al.  Identification and quantification of metabolites in 1H NMR spectra by Bayesian model selection , 2011, Bioinform..

[17]  Zerihun T. Dame,et al.  The Human Urine Metabolome , 2013, PloS one.

[18]  W. Dhillo,et al.  Utility of the urine calcium-to-creatinine ratio to diagnose primary hyperparathyroidism in asymptomatic hypercalcaemic patients with vitamin D deficiency , 2011, Annals of clinical biochemistry.

[19]  S. Moe Disorders involving calcium, phosphorus, and magnesium. , 2008, Primary care.

[20]  R. Schrier Diagnostic value of urinary sodium, chloride, urea, and flow. , 2011, Journal of the American Society of Nephrology : JASN.

[21]  M. Severi,et al.  Recovering Paleo-Records from Antarctic Ice-Cores by Coupling a Continuous Melting Device and Fast Ion Chromatography. , 2015, Analytical chemistry.

[22]  Rafael Brüschweiler,et al.  Knowns and unknowns in metabolomics identified by multidimensional NMR and hybrid MS/NMR methods. , 2017, Current opinion in biotechnology.

[23]  Dan C. Tulpan,et al.  MetaboHunter: an automatic approach for identification of metabolites from 1H-NMR spectra of complex mixtures , 2011, BMC Bioinformatics.

[24]  C. Exley,et al.  Elevated urinary excretion of aluminium and iron in multiple sclerosis , 2006, Multiple sclerosis.

[25]  J. Miller,et al.  Studies on the absorption, excretion and metabolism of dimethylsulfoxide (DMSO) in man. , 1967, The Journal of pharmacology and experimental therapeutics.

[26]  J. Lindon,et al.  Systems biology: Metabonomics , 2008, Nature.

[27]  Gary S Collins,et al.  Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration , 2015, Annals of Internal Medicine.

[28]  David S. Wishart,et al.  HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..

[29]  Wei-Qing Chen,et al.  Urinary rubidium in breast cancers. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[30]  P. Schmitt‐Kopplin,et al.  1H NMR-based metabolite profiling workflow to reduce inter-sample chemical shift variations in urine samples for improved biomarker discovery , 2016, Analytical and Bioanalytical Chemistry.

[31]  Timothy M. D. Ebbels,et al.  Modelling the acid/base 1H NMR chemical shift limits of metabolites in human urine , 2016, Metabolomics.

[32]  Leonor Puchades-Carrasco,et al.  Bioinformatics tools for the analysis of NMR metabolomics studies focused on the identification of clinically relevant biomarkers , 2016, Briefings Bioinform..

[33]  J. Freidman,et al.  Multivariate adaptive regression splines , 1991 .

[34]  Ivano Bertini,et al.  Evidence of different metabolic phenotypes in humans , 2008, Proceedings of the National Academy of Sciences.

[35]  M. Lhermitte,et al.  1H-NMR analysis of trimethylamine in urine for the diagnosis of fish-odour syndrome. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[36]  L. Tenori,et al.  Gelified Biofluids for High-Resolution Magic Angle Spinning 1H NMR Analysis: The Case of Urine. , 2017, Analytical chemistry.

[37]  E. Wolin,et al.  Guanidinium compounds in blood and urine of patients suffering from muscle disorders. , 1958, The Journal of laboratory and clinical medicine.

[38]  Josep Gómez,et al.  Dolphin: a tool for automatic targeted metabolite profiling using 1D and 2D 1H-NMR data , 2014, Analytical and Bioanalytical Chemistry.